TG Therapeutics Inc

Common Name
TG Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
370
Ticker
TGTX
Exchange
NASDAQ CAPITAL MARKET
Description
TG Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for **B‑cell–mediated diseases**, with a primary emphasis on multiple sclerosis and hematologic...

Disclosures of TG Therapeutics

Explore TG Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from TG Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of TG Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
10-K2024
10-K2023
10-K2023
10-K2022
10-K2021
10-K2020
10-K2019
10-K2018
10-K2017
10-K2016
10-K2016
10-K2015
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?